Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas.

Sagna AB, Sarr JB, Gaayeb L, Drame PM, Ndiath MO, Senghor S, Sow CS, Poinsignon A, Seck M, Hermann E, Schacht AM, Faye N, Sokhna C, Remoue F, Riveau G.

Parasit Vectors. 2013 Mar 15;6:68. doi: 10.1186/1756-3305-6-68.

2.

Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.

Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, Rossignol M, Sokhna C, Cisse B, Simondon F, Remoue F.

Malar J. 2009 Aug 13;8:198. doi: 10.1186/1475-2875-8-198.

3.

IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.

Drame PM, Machault V, Diallo A, Cornélie S, Poinsignon A, Lalou R, Sembène M, Dos Santos S, Rogier C, Pagès F, Le Hesran JY, Remoué F.

Malar J. 2012 Mar 16;11:72. doi: 10.1186/1475-2875-11-72.

4.

Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.

Sagna AB, Gaayeb L, Sarr JB, Senghor S, Poinsignon A, Boutouaba-Combe S, Schacht AM, Hermann E, Faye N, Remoue F, Riveau G.

Malar J. 2013 Aug 30;12:301. doi: 10.1186/1475-2875-12-301.

5.

First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.

Poinsignon A, Samb B, Doucoure S, Drame PM, Sarr JB, Sow C, Cornelie S, Maiga S, Thiam C, Rogerie F, Guindo S, Hermann E, Simondon F, Dia I, Riveau G, Konate L, Remoue F.

Trop Med Int Health. 2010 Oct;15(10):1198-203. doi: 10.1111/j.1365-3156.2010.02611.x. Epub 2010 Aug 17.

6.

Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker.

Drame PM, Diallo A, Poinsignon A, Boussari O, Dos Santos S, Machault V, Lalou R, Cornelie S, LeHesran JY, Remoue F.

PLoS One. 2013 Jun 20;8(6):e66354. doi: 10.1371/journal.pone.0066354. Print 2013.

7.

Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.

Badu K, Siangla J, Larbi J, Lawson BW, Afrane Y, Ong'echa J, Remoue F, Zhou G, Githeko AK, Yan G.

Malar J. 2012 Sep 10;11:318. doi: 10.1186/1475-2875-11-318.

8.

Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa.

Rizzo C, Ronca R, Fiorentino G, Mangano VD, Sirima SB, Nèbiè I, Petrarca V, Modiano D, Arcà B.

Malar J. 2011 Jul 27;10:206. doi: 10.1186/1475-2875-10-206.

9.

An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.

Londono-Renteria B, Drame PM, Weitzel T, Rosas R, Gripping C, Cardenas JC, Alvares M, Wesson DM, Poinsignon A, Remoue F, Colpitts TM.

Parasit Vectors. 2015 Oct 13;8:533. doi: 10.1186/s13071-015-1160-3.

10.

Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.

Rizzo C, Ronca R, Fiorentino G, Verra F, Mangano V, Poinsignon A, Sirima SB, Nèbiè I, Lombardo F, Remoue F, Coluzzi M, Petrarca V, Modiano D, Arcà B.

PLoS One. 2011 Mar 17;6(3):e17980. doi: 10.1371/journal.pone.0017980.

11.

Assessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites.

Ali ZM, Bakli M, Fontaine A, Bakkali N, Vu Hai V, Audebert S, Boublik Y, Pagès F, Remoué F, Rogier C, Fraisier C, Almeras L.

Malar J. 2012 Dec 31;11:439. doi: 10.1186/1475-2875-11-439.

12.

Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites.

Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M, Boulanger D, Cisse B, Sokhna C, Arcà B, Simondon F, Remoue F.

PLoS One. 2008 Jun 25;3(6):e2472. doi: 10.1371/journal.pone.0002472.

13.

Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.

Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F, Simondon F, Carnevale P, Remoue F.

PLoS One. 2010 Dec 14;5(12):e15596. doi: 10.1371/journal.pone.0015596.

14.

IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.

Stone W, Bousema T, Jones S, Gesase S, Hashim R, Gosling R, Carneiro I, Chandramohan D, Theander T, Ronca R, Modiano D, Arcà B, Drakeley C.

PLoS One. 2012;7(6):e40170. doi: 10.1371/journal.pone.0040170. Epub 2012 Jun 29.

15.

Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors.

Rizzo C, Lombardo F, Ronca R, Mangano V, Sirima SB, Nèbiè I, Fiorentino G, Modiano D, Arcà B.

Parasit Vectors. 2014 Nov 28;7:549. doi: 10.1186/s13071-014-0549-8.

16.

Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.

Drame PM, Poinsignon A, Dechavanne C, Cottrell G, Farce M, Ladekpo R, Massougbodji A, Cornélie S, Courtin D, Migot-Nabias F, Garcia A, Remoué F.

Malar J. 2015 Jul 22;14:285. doi: 10.1186/s12936-015-0800-6.

17.

First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.

Elanga Ndille E, Doucoure S, Damien G, Mouchet F, Drame PM, Cornelie S, Noukpo H, Yamadjako S, Djenontin A, Moiroux N, Misse D, Akogbeto M, Corbel V, Henry MC, Chandre F, Baldet T, Remoue F.

PLoS Negl Trop Dis. 2012;6(11):e1905. doi: 10.1371/journal.pntd.0001905. Epub 2012 Nov 15.

18.

Serological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity.

Badu K, Gyan B, Appawu M, Mensah D, Dodoo D, Yan G, Drakeley C, Zhou G, Owusu-Dabo E, Koram KA.

Parasit Vectors. 2015 Apr 28;8:251. doi: 10.1186/s13071-015-0861-y.

19.

Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors.

Sarr JB, Remoue F, Samb B, Dia I, Guindo S, Sow C, Maiga S, Tine S, Thiam C, Schacht AM, Simondon F, Konate L, Riveau G.

Malar J. 2007 Sep 1;6:117.

20.

Anopheles gambiae salivary protein expression modulated by wild Plasmodium falciparum infection: highlighting of new antigenic peptides as candidates of An. gambiae bites.

Marie A, Holzmuller P, Tchioffo MT, Rossignol M, Demettre E, Seveno M, Corbel V, Awono-Ambéné P, Morlais I, Remoue F, Cornelie S.

Parasit Vectors. 2014 Dec 20;7:599. doi: 10.1186/s13071-014-0599-y.

Items per page

Supplemental Content

Write to the Help Desk